A detailed history of Wellington Shields & Co., LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Wellington Shields & Co., LLC holds 35,826 shares of BMY stock, worth $2.07 Million. This represents 0.58% of its overall portfolio holdings.

Number of Shares
35,826
Previous 35,979 0.43%
Holding current value
$2.07 Million
Previous $1.49 Million 24.03%
% of portfolio
0.58%
Previous 0.49%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$39.66 - $51.75 $6,067 - $7,917
-153 Reduced 0.43%
35,826 $1.85 Million
Q2 2024

Aug 07, 2024

BUY
$40.25 - $52.99 $30,026 - $39,530
746 Added 2.12%
35,979 $1.49 Million
Q1 2024

May 23, 2024

SELL
$47.98 - $54.4 $83,965 - $95,200
-1,750 Reduced 4.73%
35,233 $1.91 Million
Q1 2024

May 23, 2024

BUY
$47.98 - $54.4 $83,965 - $95,200
1,750 Added 4.97%
36,983 $2.01 Million
Q1 2024

May 03, 2024

SELL
$47.98 - $54.4 $85,884 - $97,376
-1,790 Reduced 4.83%
35,233 $1.91 Million
Q4 2023

Feb 09, 2024

BUY
$48.48 - $57.85 $26,373 - $31,470
544 Added 1.49%
37,023 $1.9 Million
Q3 2023

Nov 14, 2023

BUY
$57.89 - $64.73 $810 - $906
14 Added 0.04%
36,479 $2.12 Million
Q2 2023

Aug 11, 2023

SELL
$63.71 - $70.74 $95,565 - $106,109
-1,500 Reduced 3.95%
36,465 $2.33 Million
Q1 2023

May 11, 2023

BUY
$65.71 - $74.53 $19,712 - $22,359
300 Added 0.8%
37,965 $2.63 Million
Q4 2022

Feb 14, 2023

BUY
$68.48 - $81.09 $29,104 - $34,463
425 Added 1.14%
37,665 $2.71 Million
Q3 2022

Nov 14, 2022

BUY
$0.13 - $76.84 $3 - $1,921
25 Added 0.07%
37,240 $2.65 Million
Q2 2022

Aug 12, 2022

SELL
$72.62 - $79.98 $580,960 - $639,840
-8,000 Reduced 17.69%
37,215 $2.87 Million
Q1 2022

May 09, 2022

BUY
$61.48 - $73.72 $92,220 - $110,580
1,500 Added 3.43%
45,215 $3.3 Million
Q4 2021

Feb 15, 2022

SELL
$53.63 - $62.52 $295,501 - $344,485
-5,510 Reduced 11.19%
43,715 $2.73 Million
Q3 2021

Nov 10, 2021

BUY
$59.17 - $69.31 $89,346 - $104,658
1,510 Added 3.16%
49,225 $2.91 Million
Q2 2021

Aug 12, 2021

SELL
$61.91 - $67.42 $68,101 - $74,162
-1,100 Reduced 2.25%
47,715 $3.19 Million
Q1 2021

May 12, 2021

SELL
$59.34 - $66.74 $154,284 - $173,524
-2,600 Reduced 5.06%
48,815 $3.08 Million
Q4 2020

Feb 09, 2021

SELL
$57.74 - $65.43 $40,418 - $45,801
-700 Reduced 1.34%
51,415 $3.19 Million
Q3 2020

Nov 10, 2020

BUY
$57.43 - $63.64 $28,715 - $31,820
500 Added 0.97%
52,115 $3.14 Million
Q2 2020

Aug 05, 2020

BUY
$54.82 - $64.09 $22,750 - $26,597
415 Added 0.81%
51,615 $3.04 Million
Q1 2020

May 07, 2020

SELL
$46.4 - $67.43 $28,304 - $41,132
-610 Reduced 1.18%
51,200 $2.85 Million
Q4 2019

Feb 11, 2020

BUY
$49.21 - $64.19 $2.55 Million - $3.33 Million
51,810 New
51,810 $3.33 Million
Q3 2019

Nov 05, 2019

SELL
$42.77 - $50.71 $1.85 Million - $2.2 Million
-43,350 Closed
0 $0
Q2 2019

Aug 08, 2019

SELL
$44.62 - $49.34 $8,924 - $9,868
-200 Reduced 0.46%
43,350 $1.97 Million
Q1 2019

May 10, 2019

SELL
$45.12 - $53.8 $182,736 - $217,890
-4,050 Reduced 8.51%
43,550 $2.08 Million
Q4 2018

Feb 11, 2019

BUY
$48.76 - $63.23 $173,098 - $224,466
3,550 Added 8.06%
47,600 $2.47 Million
Q3 2018

Nov 06, 2018

SELL
$55.19 - $62.25 $11,038 - $12,450
-200 Reduced 0.45%
44,050 $2.74 Million
Q2 2018

Aug 02, 2018

SELL
$50.53 - $62.98 $30,318 - $37,788
-600 Reduced 1.34%
44,250 $2.45 Million
Q1 2018

May 03, 2018

BUY
$59.92 - $68.98 $5,992 - $6,898
100 Added 0.22%
44,850 $0
Q4 2017

Feb 06, 2018

SELL
$59.94 - $65.35 $105,134 - $114,623
-1,754 Reduced 3.77%
44,750 $2.74 Million
Q3 2017

Nov 06, 2017

BUY
$55.23 - $63.74 $2.57 Million - $2.96 Million
46,504
46,504 $0

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Wellington Shields & Co., LLC Portfolio

Follow Wellington Shields & Co., LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wellington Shields & Co., LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wellington Shields & Co., LLC with notifications on news.